A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
A prior screening programme carried out using MTT assay by our group identified a series of novel benzimidazole derivatives, among which Methyl 2-(5-fluoro-2- hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) showed highest anticancer efficacy compared to that of chemotherapeutic agent, cisp...
| Main Authors: | Dai, X., Wang, L., Deivasigamni, A., Looi, C., Karthikeyan, C., Trivedi, P., Chinnathambi, A., Alharbi, S., Arfuso, Frank, Dharmarajan, Arunasalam, Goh, B., Hui, K., Kumar, Alan Prem, Mustafa, M., Sethi, Gautam |
|---|---|
| Format: | Journal Article |
| Published: |
Impact Journals LLC
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/50403 |
Similar Items
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
by: Swamy, S., et al.
Published: (2016)
by: Swamy, S., et al.
Published: (2016)
Mobile business intelligent center (MBIC)
by: Abd. Jalil, Rohaizan
Published: (2007)
by: Abd. Jalil, Rohaizan
Published: (2007)
Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2016)
by: Dai, X., et al.
Published: (2016)
Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
by: Singh, S., et al.
Published: (2015)
by: Singh, S., et al.
Published: (2015)
Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
by: Raghunath, A., et al.
Published: (2018)
by: Raghunath, A., et al.
Published: (2018)
Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cells
by: Mohan, C., et al.
Published: (2018)
by: Mohan, C., et al.
Published: (2018)
The expression of tumor necrosis factor-alpha, its receptors and steroidogenic acute regulatory protein during corpus luteum regression
by: Abdo, M., et al.
Published: (2008)
by: Abdo, M., et al.
Published: (2008)
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma
by: Abbhi, V., et al.
Published: (2017)
by: Abbhi, V., et al.
Published: (2017)
Multifunctional Properties of Chicken Embryonic Prenatal Mesenchymal Stem Cells- Pluripotency, Plasticity, and Tumor Suppression
by: Bhuvanalakshmi, G., et al.
Published: (2014)
by: Bhuvanalakshmi, G., et al.
Published: (2014)
Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: The role of p38 MAPK and ROS
by: Woo, C., et al.
Published: (2013)
by: Woo, C., et al.
Published: (2013)
Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines
by: Deshmukh, A., et al.
Published: (2017)
by: Deshmukh, A., et al.
Published: (2017)
Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators
by: Bhuvanalakshmi, G., et al.
Published: (2017)
by: Bhuvanalakshmi, G., et al.
Published: (2017)
N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-kB signaling pathway
by: Mohan, C., et al.
Published: (2018)
by: Mohan, C., et al.
Published: (2018)
The Effects of Combination Treatment Using Phenoxodiol and Docetaxel, and Phenoxodiol and Secreted Frizzled-related Protein 4 on Prostate Cancer Cell Lines
by: Mahoney, S., et al.
Published: (2014)
by: Mahoney, S., et al.
Published: (2014)
Role of Wnt signalling in early pregnancy
by: Nayeem, S., et al.
Published: (2015)
by: Nayeem, S., et al.
Published: (2015)
Wnt signaling in triple-negative breast cancer
by: Pohl, S., et al.
Published: (2017)
by: Pohl, S., et al.
Published: (2017)
Breast cancer stem-like cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt ß-catenin signaling via the Wnt antagonist secreted frizzled related protein-4
by: Bhuvanalakshmi, G., et al.
Published: (2017)
by: Bhuvanalakshmi, G., et al.
Published: (2017)
NF-κB in cancer therapy
by: Li, F., et al.
Published: (2015)
by: Li, F., et al.
Published: (2015)
Wnt antagonist, secreted frizzled-related protein 4 (SFRP4) and peptides from its associated domains, increases chemotherapeutic response of cancer stem cells of malignant mesothelioma cell lines
by: Perumal, V., et al.
Published: (2017)
by: Perumal, V., et al.
Published: (2017)
Regulation of cancer stem cell metabolism by secreted frizzled-related protein 4 (SFRP4)
by: Deshmukh, Abhijeet, et al.
Published: (2018)
by: Deshmukh, Abhijeet, et al.
Published: (2018)
The Role of Secreted Frizzled Related Protein 4 (sFRP-4) in Regulating Oestradiol-Induced Growth of the MCF-7 Breast Cancer Cell Line
by: McLaren, S., et al.
Published: (2014)
by: McLaren, S., et al.
Published: (2014)
Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
by: Manu, K., et al.
Published: (2018)
by: Manu, K., et al.
Published: (2018)
Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)
by: Shanmugam, M., et al.
Published: (2018)
Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes
by: Regan, S., et al.
Published: (2018)
by: Regan, S., et al.
Published: (2018)
Secreted frizzled-related protein 4 and its implications in cancer and apoptosis
by: Pohl, S., et al.
Published: (2015)
by: Pohl, S., et al.
Published: (2015)
Hepatocellular Carcinoma
by: Tirnitz-Parker, Janine
Published: (2019)
by: Tirnitz-Parker, Janine
Published: (2019)
Potential protective effects of ursolic acid against gamma irradiation-induced damage are mediated through the modulation of diverse inflammatory mediators
by: Wang, H., et al.
Published: (2017)
by: Wang, H., et al.
Published: (2017)
Mitochondrial ROS and involvement of Bcl-2 as a mitochondrial ROS regulator
by: Chong, S., et al.
Published: (2014)
by: Chong, S., et al.
Published: (2014)
JNK 572/3 - Pembuatan Lanjutan
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2004)
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2004)
Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
by: Bhuvanalakshmi, G., et al.
Published: (2019)
by: Bhuvanalakshmi, G., et al.
Published: (2019)
The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines
by: Visweswaran, M., et al.
Published: (2017)
by: Visweswaran, M., et al.
Published: (2017)
Role of epigenetic modulation in cancer stem cell fate
by: Deshmukh, A., et al.
Published: (2017)
by: Deshmukh, A., et al.
Published: (2017)
Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan–dextran sulfate nanoparticles enhances their expression and anti-cancer effects
by: Perumal, Vanathi, et al.
Published: (2017)
by: Perumal, Vanathi, et al.
Published: (2017)
Function of caspase-14 in trophoblast differentiation
by: White, L., et al.
Published: (2009)
by: White, L., et al.
Published: (2009)
Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties
by: Bhuvanalakshmi, G., et al.
Published: (2015)
by: Bhuvanalakshmi, G., et al.
Published: (2015)
Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-?B signaling cascade in gastric cancer
by: Manu, K., et al.
Published: (2015)
by: Manu, K., et al.
Published: (2015)
Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)
by: Shanmugam, M., et al.
Published: (2016)
Role of RNF20 in cancer development and progression – a comprehensive review
by: Sethi, G., et al.
Published: (2018)
by: Sethi, G., et al.
Published: (2018)
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
by: Dai, X., et al.
Published: (2015)
by: Dai, X., et al.
Published: (2015)
Selenium and hepatocellular carcinoma
by: Nasar Alwahaibi,, et al.
Published: (2008)
by: Nasar Alwahaibi,, et al.
Published: (2008)
Similar Items
-
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
by: Swamy, S., et al.
Published: (2016) -
Mobile business intelligent center (MBIC)
by: Abd. Jalil, Rohaizan
Published: (2007) -
Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2016) -
Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
by: Singh, S., et al.
Published: (2015) -
Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
by: Raghunath, A., et al.
Published: (2018)